Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Doses of BTZ043 in Healthy Adult Volunteers
Conditions
Interventions
BTZ-043
Placebo
Locations
1
Germany
Nuvisan
Neu-Ulm, Bavaria, Germany
Start Date
June 7, 2018
Primary Completion Date
August 14, 2018
Completion Date
March 5, 2019
Last Updated
March 7, 2019
NCT06704048
NCT06192160
NCT05947890
NCT05989802
NCT06272812
NCT02354014
Lead Sponsor
Michael Hoelscher
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions